Logo

Evotec, Biogen Idec Strike Screening Pact

Sep 10, 2009

NEW YORK (GenomeWeb News) – Evotec has agreed to provide Biogen Idec with high-throughput screening and assay development services for a particular target, Evotec said today.

Evotec said that it will use its protein production, assay development, and screening technologies to identify drug candidates for Biogen Idec. The agreement also includes an option to cover further targets.

"We believe that the quality of future drug candidates is very much dependent on the identification of high quality starting points," Evotec's Executive VP of Business Development, Mark Ashton, said in a statement.

Financial terms of the agreement were not released.

Filed under

Drug Discovery & Development
drug screening
Biogen
Evotec
Breaking News
The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.